Free Trial
NASDAQ:STSS

Sharps Technology Q4 2023 Earnings Report

Sharps Technology logo
$3.83 -0.22 (-5.43%)
Closing price 05/27/2025 04:00 PM Eastern
Extended Trading
$3.86 +0.04 (+0.91%)
As of 04:48 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Sharps Technology EPS Results

Actual EPS
-$1,056.00
Consensus EPS
N/A
Beat/Miss
N/A
One Year Ago EPS
N/A

Sharps Technology Revenue Results

Actual Revenue
N/A
Expected Revenue
N/A
Beat/Miss
N/A
YoY Revenue Growth
N/A

Sharps Technology Announcement Details

Quarter
Q4 2023
Time
N/A
Conference Call Date
Friday, March 29, 2024
Conference Call Time
8:00AM ET

Earnings Documents

Sharps Technology Earnings Headlines

Sharps Technology Regains Nasdaq Compliance
F1 Engineering Powers This Electric Marine Motor
The future of marine propulsion has arrived - powered by F-1 grade engineering. In collaboration with McLaren Engineering, a NASDAQ-listed marine tech company unveiled a groundbreaking new electric powertrain set to transform the industry.
Sharps Technology Inc.
See More Sharps Technology Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like Sharps Technology? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Sharps Technology and other key companies, straight to your email.

About Sharps Technology

Sharps Technology (NASDAQ:STSS), a medical device company, researches, designs, develops, manufactures, distributes, and sells safety syringe products in the United States. It offers Sharps Provensa, an ultra-low waste space syringe for the administration of various vaccines and injectable medications. Sharps Technology, Inc. was incorporated in 2017 and is based in Melville, New York.

View Sharps Technology Profile

More Earnings Resources from MarketBeat